Alan F. Denenberg
Lawyers

Filters
NeoGenomics Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the follow-on offering of 8,050,000 shares of common stock of…
Fastly, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $207 million initial public offering of common stock of Fastly, Inc. Fastly’s common stock is listed…
Roku, Inc. SEC-Registered At-The-Market Offering
Davis Polk advised the agent bank on the SEC-registered at-the-market offering by Roku, Inc. of up to 1,000,000 shares of its Class A common stock.
Roku pioneered streaming to the TV and is…
Uber Technologies $8.1 billion IPO
Davis Polk advised the underwriters in connection with the $8.1 billion initial public offering of 180,000,000 shares of common stock of Uber Technologies, Inc. Uber’s common stock is…
Endava plc $156 Million Secondary Offering
Davis Polk advised the several underwriters in connection with the secondary offering of 5,750,000 American Depositary Shares, each representing one Class A ordinary share of…
Natera, Inc. $100 Million Follow-On Public Offering
Davis Polk advised the several underwriters in connection with the follow-on offering of 5,263,158 shares of common stock of Natera, Inc. for total gross proceeds of approximately $100…
Davis Polk Advises Ultra Clean on Its Acquisition of Dynamic Manufacturing Solutions
Davis Polk advised Ultra Clean Holdings, Inc. on its acquisition of substantially all of the assets of Dynamic Manufacturing Solutions, LLC for $30.0 million in cash, subject to post…
Roku, Inc. $100 Million At-The-Market Offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Roku, Inc. of its Class A common stock for up to an aggregate amount of $100 million.
Roku pioneered…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock for an aggregate price to the public of approximately $111.4…
Horizon Pharma Follow-On Offering
Davis Polk advised the underwriters in connection with the $345 million public offering of ordinary shares of Horizon Pharma plc. Horizon’s ordinary shares are listed on the NASDAQ Global…